{"id":276,"date":"2019-12-20T11:29:14","date_gmt":"2019-12-20T11:29:14","guid":{"rendered":"https:\/\/sheetal-work.colibriwp.com\/pharmadesk\/?p=276"},"modified":"2019-12-20T11:29:14","modified_gmt":"2019-12-20T11:29:14","slug":"which-of-the-mri-guided-neurosurgical-ablation-market-players-are-leading-and-what-are-their-key-differential-strategies-to-retain-their-stronghold","status":"publish","type":"post","link":"https:\/\/sheetal-work.colibriwp.com\/pharmadesk\/which-of-the-mri-guided-neurosurgical-ablation-market-players-are-leading-and-what-are-their-key-differential-strategies-to-retain-their-stronghold\/","title":{"rendered":"MRI-Guided Neurosurgical Ablation Market Size Predicted to Register a CAGR of 4.3% in 2019-2026"},"content":{"rendered":"<h2><strong>The global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026.<\/strong><\/h2>\n<ul>\n<li><strong>Which of the market players are leading and what are their key differential strategies to retain their stronghold?<br \/>\n<\/strong><strong>&#8211; The major players profiled in the report include Medtronic plc., Boston Scientific Corporation,\u00a0 InSightec Ltd., Monteris Medical Corporation, MRI Interventions, INC., and AngioDynamics Inc.<\/strong><\/li>\n<\/ul>\n<p>The report analyzes and forecasts the\u00a0<strong>MRI-Guided Neuros\u00a0 urgical Ablation<\/strong>\u00a0market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.<\/p>\n<p><strong>DOWNLOAD FREE SAMPLE<br \/>\n<\/strong><a href=\"https:\/\/www.acumenresearchandconsulting.com\/request-sample\/1554\">https:\/\/www.acumenresearchandconsulting.com\/request-sample\/1554<\/a><\/p>\n<p>The report comprises a detailed value chain analysis, which provides a comprehensive view of the global\u00a0<strong>MRI-Guided Neurosurgical Ablation<\/strong>\u00a0market. The Porter\u2019s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.<\/p>\n<p><strong>Market Dynamics<\/strong><\/p>\n<p>The increasing demand for non-invasive treatment for surgical procedures across the globe is primarily driving the market growth. The benefits offered by minimally invasive surgeries include minimum pain, high accuracy rate, reduced scarring, and low complication risk are accelerating the demand of MRI-guided neurosurgical ablation. The rising incidences of brain cancer and technological advancements associated with the techniques for the treatment across the globe is further stimulating the demand in the market. There are more than 120 types of brain and CNS tumors, which accounted for more than 0.33 million cases of CNS cancer and 0.22 million deaths globally. Additionally, according to National Institutes of Health (NIH), an estimated 23,820 new cases\u00a0 of brain cancer are projected to be detected in the year 2019 in the U.S. Along with this, favorable reimbursement policies are also expected to drive demand over the forecast period. The certain advantages offered by accessories segments such as functionality, maneuverability, and precision to ensure patient safety during surgical procedures are also boosting the demand in the market.<\/p>\n<p>On the other hand, the high cost associated with the MRI scanning and shortage of skilled neurosurgical workforce is likely to hamper the market growth over the forecast period. Whereas, emerging economies across the globe are expected to provide potential opportunity over the forecast period.<\/p>\n<p>On the basis of product, the market is segmented into Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, and MRI-guided Radiofrequency Ablation Systems. From the aforementioned segments, accessories segment is accountable for the maximum share in the year 2018, owing to the rising adoption of advanced medical devices and accessories in hospitals. Along with this, the rising prevalence of brain cancer across the globe is again a factor fuelling the market value. MRI-guided laser ablation systems hold the second largest share in the product segment of MRI-guided neurosurgical ablation market.<\/p>\n<p>On the basis of end-use, the market is segmented into clinics, ambulatory surgical centers, and hospitals. Hospitals accounted for the largest market share of MRI-guided neurosurgical ablation in terms of end-user. Number of hospitals are growing owing to the increasing prevalence of surgical procedures across the globe. Along with this, rising government spending on the development of healthcare infrastructure, coupled with the increasing number of cases of chronic disorders are expected to contribute to the segment growth over the forecast period. Apart from this, the segment is also expected to continue with the same pace over the forecast period. Moreover, increasing discretionary income is also contributing to the segment growth.<\/p>\n<p><strong>Market Segmentation<\/strong><\/p>\n<p>Market By Product<\/p>\n<ul>\n<li>Accessories<\/li>\n<li>MRI-guided Laser Ablation Systems<\/li>\n<li>MRI-guided Focused Ultrasound Systems<\/li>\n<li>MRI-guided Radiofrequency Ablation Systems<\/li>\n<\/ul>\n<p>Market By End-Use<\/p>\n<ul>\n<li>Clinics<\/li>\n<li>Ambulatory Surgical Centers<\/li>\n<li>Hospitals<\/li>\n<\/ul>\n<p>Market By Geography<\/p>\n<ul>\n<li>North America<\/li>\n<li>Europe<\/li>\n<li>Asia-Pacific<\/li>\n<li>Latin America<\/li>\n<li>Middle East &amp; Africa<\/li>\n<\/ul>\n<p><strong>Table Of Content<\/strong><\/p>\n<p><strong>Chapter 1. Industry Overview of MRI-guided Neurosurgical Ablation<\/strong><\/p>\n<p><strong>Chapter 2. Market Dynamics and Competition Analysis<\/strong><br \/>\n<strong><br \/>\nChapter 3. MRI-guided Neurosurgical Ablation Market By Product<\/strong><\/p>\n<p><strong>Chapter 4. MRI-guided Neurosurgical Ablation Market By End Use<\/strong><\/p>\n<p><strong>Chapter 5. North America MRI-guided Neurosurgical Ablation Market By Country<\/strong><\/p>\n<p><strong>Chapter 6. Europe MRI-guided Neurosurgical Ablation Market By Country<\/strong><br \/>\n<strong><br \/>\nChapter 7. Asia-Pacific MRI-guided Neurosurgical Ablation Market By Country<\/strong><\/p>\n<p><strong>Chapter 8. Latin America MRI-guided Neurosurgical Ablation Market By Country<\/strong><\/p>\n<p><strong>Chapter 9. Middle East &amp; Africa MRI-guided Neurosurgical Ablation Market By Country<\/strong><br \/>\n<strong><br \/>\nChapter 10. Player Analysis of MRI-guided Neurosurgical Ablation<\/strong><br \/>\n<strong><br \/>\nChapter 11. Research Approach<\/strong><\/p>\n<p>The report provides size (in terms of volume and value) of\u00a0<strong>MRI-Guided Neurosurgical Ablation<\/strong>\u00a0market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.<\/p>\n<p>In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants\u2019 insights, and recognizing business opportunities.<\/p>\n<p><strong>Key Questions Answered in the Report<\/strong><\/p>\n<p>The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-<\/p>\n<ul>\n<li>What is the overall structure of the market?<\/li>\n<li>What was the historical value and what is the forecasted value of the market?<\/li>\n<li>What are the key product level trends in the market?<\/li>\n<li>What are the market level trends in the market?<\/li>\n<li>Which of the market players are leading and what are their key differential strategies to retain their stronghold?<\/li>\n<li>Which are the most lucrative regions in the market space?\n<p><strong>REQUEST CUSTOMIZATION<br \/>\n<a href=\"https:\/\/www.acumenresearchandconsulting.com\/request-customization\/1554\">https:\/\/www.acumenresearchandconsulting.com\/request-customization\/1554<\/a><\/strong><strong>BUY THIS PREMIUM REPORT<\/strong><br \/>\n<strong><a href=\"https:\/\/www.acumenresearchandconsulting.com\/buy-now\/0\/1554\">https:\/\/www.acumenresearchandconsulting.com\/buy-now\/0\/1554<\/a><br \/>\n<\/strong><\/li>\n<\/ul>\n<div class=\"saboxplugin-wrap\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. Which of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"seo_booster_metabox":"","footnotes":""},"categories":[193,121],"tags":[291,293,292,290],"class_list":["post-276","post","type-post","status-publish","format-standard","hentry","category-business","category-pharma","tag-mri-guided-neurosurgical-ablation-market","tag-mri-guided-neurosurgical-ablation-market-shares","tag-mri-guided-neurosurgical-ablation-market-size","tag-which-of-the-mri-guided-neurosurgical-ablation-market-players-are-leading-and-what-are-their-key-differential-strategies-to-retain-their-stronghold"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/sheetal-work.colibriwp.com\/pharmadesk\/wp-json\/wp\/v2\/posts\/276","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sheetal-work.colibriwp.com\/pharmadesk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sheetal-work.colibriwp.com\/pharmadesk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sheetal-work.colibriwp.com\/pharmadesk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sheetal-work.colibriwp.com\/pharmadesk\/wp-json\/wp\/v2\/comments?post=276"}],"version-history":[{"count":1,"href":"https:\/\/sheetal-work.colibriwp.com\/pharmadesk\/wp-json\/wp\/v2\/posts\/276\/revisions"}],"predecessor-version":[{"id":277,"href":"https:\/\/sheetal-work.colibriwp.com\/pharmadesk\/wp-json\/wp\/v2\/posts\/276\/revisions\/277"}],"wp:attachment":[{"href":"https:\/\/sheetal-work.colibriwp.com\/pharmadesk\/wp-json\/wp\/v2\/media?parent=276"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sheetal-work.colibriwp.com\/pharmadesk\/wp-json\/wp\/v2\/categories?post=276"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sheetal-work.colibriwp.com\/pharmadesk\/wp-json\/wp\/v2\/tags?post=276"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}